On April 5, 2023 at 10:58:01 ET an unusually large $172.00K block of Call contracts in Ocuphire Pharma (OCUP) was…
Clinical-stage ophthalmic biopharmaceutical company Ocuphire Pharma, Inc. (US:OCUP) announced its fourth-quarter and year-end financial results on March 30, indicating a successful…